A nonclonogenic cytotoxicity assay using primary cultures of patient tumor cells for anticancer drug screening

Journal of Biomolecular Screening

Volumn 3, Issue 3, 1998, Pages 207-216

  Dhar, Sumeer ^a   Gullbo, Joachim ^a   Nilsson, Kenneth ^a   Nygren, Peter ^a   Larsson, Rolf ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000356151     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/108705719800300307     Document Type: Article

References (13)

1. Frei, E. (1982). The national cancer chemotherapy program. Science 217:600-606.
2. Venditti, J.M. (1981). Preclinical drug development: Rationale and methods. Semin. Oncol. 8:349-361.
3. Grindley, G. (1990). Current status of cancer drug development: Failure or limited success? Cancer Cells. 2:163-171.
4. Alley, M, Scudeiro, D., Monks, A., Hursey, M., Czerwinski, M., Fine, D., Abbott, B., Mayo, J., Shoemaker, R., Boyd, M. (1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:589-601.
5. Monks, A., et al. (1991). Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Nail. Cancer Inst. 83:757-765.
6. Paull, K., Shoemaker, R., Hodes, L., Monks, A., Scudeiro, D., Rubinstein, L., Plowman, J., Boyd, M. (1989). Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE alogrithm. J. Natl. Cancer Inst. 81:1088-1092.
7. Weinstein, J., et al. (1992). Neural computing in cancer drug development: Predicting mechanism of action. Science. 258:447-451.
8. Weinstein, J., et al. (1994). Predictive statistics and artificial intelligence in the US National Cancer Institute's drug discovery program for cancer and AIDS. Stem Cells. 12:13-22.
9. Weinstein, J.N., et al. (1997). An information-intensive approach to the molecular pharmacology of cancer. Science. 275:343-349.
10. Fruehauf, J.P., Bosanquet, A.G. (1993). In Vitro Determination of Drug Response: A Discussion of Clinical Applications. JP Fruehauf and AG Bosanquet (eds.), Lippincott-Raven, Philadelphia, PA.
11. Weisenthal, L.M., Lippman, M.E. (1985). Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treatment Rep. 69:615-631.
12. Shoemaker, R., et al. (1985). Application of a human tumor colony-forming assay to new drug screening. Cancer Res. 45:2145-2153.
13. Weisenthal, L. (1994). Clinical correlations for cell culture assays based on the concept of total tumor cell kill. In Chemosensitivity in gynecologic malignancies and breast cancer, p. 82-90. Karger, Basel.